Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. (ticker: GLSI) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of GLSI's SEC filings surfaces 10 active risk signals, including 9 late-filing signals, and 1 auditor-change signal. GLSI reported no tagged revenue in revenue and -$11.44M for the period ending 2025-09-30, with operating cash flow of -$6.74M. Cash and equivalents stood at $3.81M (down 34.6% year-over-year). Total assets of $3.81M exceed total liabilities of $1.62M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.